- $1.48m
- -$0.21m
- $6.84m
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Invo Fertility Announces Third Quarter 2025 Financial Results
Brief: Invo Fertility Files For Non Timely 10-Q With US SEC
Brief: INVO Fertility Says Wood Violet To Pay $6,010,000 In Settlement To Elizabeth Pritts - SEC Filing
Brief: INVO Fertility Announces A 13 Reverse Stock Split Effective Pre-Market Opening On July 21, 2025
Brief: INVO Fertility Receives Notice of Allowance for Modified INVOcell Device Patent
Invo Fertility Inc Expected To Post A Loss Of $3.50 A Share: Earnings Preview
Invo Fertility Inc Expected To Post A Loss Of $3.48 A Share: Earnings Preview
Naya Biosciences Inc Expected To Post A Loss Of $3.48 A Share: Earnings Preview
Brief: Naya Biosciences Inc - Regains Compliance With Nasdaq Listing Rule - SEC Filing
Brief: Naya Biosciences Announces Development Of NY-500
Brief: Invo Bioscience Confirms Corporate Name Change And New Trading Symbol
Brief: INVO - Entered Fourth Amendment To Previously Announced Agreement & Plan Of Merger By INVO Merger Sub And NAYA Biosciences
Brief: Invo Bioscience On June 18, 2024, Co Received Notice From Nasdaq Informing Co Was Granted Request For Continued Listing On Nasdaq
Brief: Invo Bioscience Inc Files For Mixed Shelf Of Up To $100 Million
INVO rises as partner NAYA to acquire gene therapy company
Brief: Invo Bioscience - Entered Into Second Amendment To Merger Agreement By Invo Merger And Naya Biosciences, On Dec 27
Brief: NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK Bispecific Antibody in the American Society of Hematology's Blood Journal
Brief: Naya Biosciences And Onk Therapeutics Announce Research Partnership To Advance Combination Therapy Of Flex-NK™ Bispecific Antibodies And Optimally Engineered Off-The-Shelf Natural Killer Cell Therapies